We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Can Effectively Identify Hip Dysplasia at Six Months

By MedImaging International staff writers
Posted on 20 Feb 2012
Developmental dysplasia of the hip (DDH) is a common congenital disorder in which a child’s upper thighbone is dislocated from the hip socket. The disorder can be present at birth or develop during a child’s first year of life. Plain radiography has long been the gold standard screening modality for this condition in six-month-old children, in spite of worries over exposing very young children to ionizing radiation. However, according to a new study findings, ultrasound provided good quality images with 100% diagnostic correlation to the X-rays in all patients. Ultrasound was shown to be an effective alternative imaging method instead of X-rays for DDH screening in five-to-seven-month-old children.

In new research presented by investigators from the Hospital For Special Surgery (New York, NY, USA) at the 2012 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) held in San Francisco (CA, USA) on February 7-11, 35 five-to-seven-month-old children at high risk for DDH were screened with the conventional pelvis X-ray, as well as a bilateral nonstress-hip ultrasounds. Blinded orthopedic surgeons then assessed the radiographs and ultrasound scans for standard measure of hip dysplasia. Of the 35 children involved in the study, only one was diagnosed with dysplasia, and the diagnosis was made on both the ultrasound and X-ray.

Related Links:

Hospital For Special Surgery


Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Mammo DR Retrofit Solution
DR Retrofit Mammography
MRI System
nanoScan MRI 3T/7T
Biopsy Software
Affirm® Contrast

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.